SCHEMBL4067164

SCHEMBL4067164

O=C(CCc1ccccc1)NCc1cccnc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 1.00
CYP1A2 P05177 1/20 1.00
CYP2C9 P11712 1/20 1.00
CYP2C19 P33261 1/20 1.00
PAX8 Q06710 1/20 0.73
MAPT P10636 1/20 0.73
SMN1; SMN2 Q16637 3/20 0.69
HTT P42858 2/20 0.69
KMT2A Q03164 2/20 0.69
LMNA P02545 2/20 0.66
HPGD P15428 2/20 0.66
ALDH1A1 P00352 4/20 0.65
L3MBTL1 Q9Y468 1/20 0.61
ALOX15 P16050 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
RECQL P46063 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16610098 0.89 MAPT (0.84) CYP3A4CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL13271684 0.89 CYP3A4 (0.80) CYP3A4CYP1A2CYP2C9CYP2C19PAX8
SCHEMBL16353842 0.86 CYP3A4 (0.76) CYP3A4CYP1A2CYP2C9CYP2C19PAX8
SCHEMBL28687306 0.85 CYP3A4 (0.73) CYP3A4CYP1A2CYP2C9CYP2C19PAX8
SCHEMBL1566393 0.85 CYP3A4 (0.73) CYP3A4CYP1A2CYP2C9CYP2C19PAX8
SCHEMBL29354343 0.85 CYP3A4 (0.73) CYP3A4CYP1A2CYP2C9CYP2C19PAX8
SCHEMBL28497414 0.84 LMNA (0.86) CYP3A4CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL30172092 0.84 LMNA (0.86) CYP3A4CYP1A2CYP2C9CYP2C19MAPT
SCHEMBL4075670 0.84 CYP1A2 (0.73) CYP3A4CYP1A2CYP2C9CYP2C19PAX8
SCHEMBL4071835 0.84 CYP1A2 (0.73) CYP3A4CYP1A2CYP2C9CYP2C19PAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1190963-A 2-amino-benzoxanones for the treatment of viral infections SEARLE & CO (US) 1998-08-19 CN claimed
EP-1415986-B1 SPIRO ISOBENZOFURANES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS BANYU PHARMA CO LTD (JP) 2009-04-08 EP disclosed
US-7205417-B2 Spiro compounds BANYU PHARMACEUTICAL CO., LTD. (JP) 2007-04-17 US disclosed